Search research articles
Contact Us
Filters
Showing results (221-230 of 288) with videos related to
Page
of 29
Sort By:
Journal of Neuroinflammation
|
April 25, 2020
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
Elisabeth Maillart, Françoise Durand-Dubief, Céline Louapre, et al.
Neurology
|
October 12, 2023
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality
Fabien Rollot, Zoé Uhry, Emmanuelle Dantony, et al.
Archives of Neurology
|
July 11, 2012
Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients
Guillaume Taieb, Claire Duflos, Dimitri Renard, et al.
Journal of Neurology
|
February 14, 2019
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
Alvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Journal of Neurology
|
January 5, 2019
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
Alvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Journal of Neuroinflammation
|
July 4, 2019
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
Alvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, et al.
The Lancet Regional Health. Europe
|
November 25, 2022
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study
Sarah Wilson, Floriane Calocer, Fabien Rollot, et al.
JAMA Network Open
|
June 23, 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
Edouard Januel, David Hajage, Pierre Labauge, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 23, 2020
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
Sophie Mathais, Xavier Moisset, Bruno Pereira, et al.
Brain : a Journal of Neurology
|
April 27, 2017
A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies
Marie Coutelier, Giulia Coarelli, Marie-Lorraine Monin, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 288) with videos related to
Sort By:
Page
of 29
Journal of Neuroinflammation
|
April 25, 2020
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies
Elisabeth Maillart, Françoise Durand-Dubief, Céline Louapre, et al.
Neurology
|
October 12, 2023
Comparison of 2 Methods for Estimating Multiple Sclerosis-Related Mortality
Fabien Rollot, Zoé Uhry, Emmanuelle Dantony, et al.
Archives of Neurology
|
July 11, 2012
Long-term outcomes of CLIPPERS (chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids) in a consecutive series of 12 patients
Guillaume Taieb, Claire Duflos, Dimitri Renard, et al.
Journal of Neurology
|
February 14, 2019
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
Alvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Journal of Neurology
|
January 5, 2019
Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults
Alvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Journal of Neuroinflammation
|
July 4, 2019
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
Alvaro Cobo-Calvo, María Sepúlveda, Fabien Rollot, et al.
The Lancet Regional Health. Europe
|
November 25, 2022
Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: A retrospective observational cohort study
Sarah Wilson, Floriane Calocer, Fabien Rollot, et al.
JAMA Network Open
|
June 23, 2023
Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis
Edouard Januel, David Hajage, Pierre Labauge, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
September 23, 2020
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
Sophie Mathais, Xavier Moisset, Bruno Pereira, et al.
Brain : a Journal of Neurology
|
April 27, 2017
A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies
Marie Coutelier, Giulia Coarelli, Marie-Lorraine Monin, et al.
Page
of 29